Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
14:34
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

WFH 2016 World Congress

 

24-28 July 2016 Orlando
FAQs
   
Discussion forum - WFH 2016 World Congress
    Topic - Novel therapeutic agents

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 96
Visits: 10
Title: In-vitro Evaluation of Factor VIIa-CTP, a Novel Long-Acting Coagulation Factor
Authors: Gili Hart ,
Centre: OPKO Biologics

You must be registered to reply or comment.

IN-VITRO EVALUATION OF FACTOR VIIA-CTP, A NOVEL LONG-ACTING COAGULATION FACTOR

Gili Hart
Thread initiator
Subspeciality
Reg: 6/10/2015 9:11:00 AM
Comment# 1
I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 7/5/2016 10:29:00 AM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 13
Visits: 590
Title: Algorithmic evidence-based phenotype screening and collaborative approach to attacking symptoms of nonadherence in patients with bleeding disorders
Authors: Jay Bryant-Wimp , Jay Bryant-Wimp, RPh
Centre: Integrite Solutions

Poster most viewed in this topic
Poster: 98
Visits: 72
Title: Factor VIIa-CTP , a novel FVIIa potentially supporting subcutaneous treatment - comprehensive assessment in Hemophilic animals models in preparation for first in human study.
Authors: Gili Hart ,
Centre: OPKO Biologics


 






PosterSessionOnline
Logo Draft
 
Logo Cert